BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• 

  Deals

  Pharma Tuck-In Deals Grow After a Mediocre First Quarter for Small Biotechs

  Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical milestones on the horizon.

  June 4, 2025

   · 

  4 min read

   · 

  Annalee Armstrong
• Press Releases

  New analyses reinforce long-term benefit of DARZALEX® (daratumumab) subcutaneous-based quadruplet regimen for patients with newly diagnosed multiple myeloma

  June 4, 2025

   · 

  18 min read
• Press Releases

  Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

  June 4, 2025

   · 

  35 min read
• Press Releases

  Single infusion of CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma

  June 4, 2025

   · 

  14 min read
• Press Releases

  Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma

  June 4, 2025

   · 

  29 min read
• Press Releases

  Early results from Johnson & Johnson’s trispecific antibody show promising response in heavily pretreated multiple myeloma patients

  June 4, 2025

   · 

  7 min read
• Press Releases

  DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimen shows 95 percent progression-free survival at four years in transplant-eligible, newly diagnosed patients with multiple myeloma who achieved sustained MRD negativity

  June 4, 2025

   · 

  25 min read
• Press Releases

  Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection

  June 4, 2025

   · 

  4 min read
• 

  Venture capitalists

  Boom, Bust and Recover: What Happens Next as Biotech VC Cycle Resets

  A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create and invest in companies, just more carefully.

  June 4, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Business

  Opinion: Investing in Research and Welcoming Global Talent Strengthens America

  Recent decisions to reduce health and science research funding and limit the participation of international students and researchers could prove damaging in the short and long term.

  June 4, 2025

   · 

  4 min read

   · 

  Dr. Chris Otiko